ProQuest Investments IV, L.P.
10% owner at EAGLE PHARMACEUTICALS, INC.; 10% owner at Immune Design Corp.
- Sold, on record
- $27.3M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Nov 9, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- EAGLE PHARMACEUTICALS, INC.10% owner
- Immune Design Corp.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- EAGLE PHARMACEUTICALS, INC.304,595 shares
- Immune Design Corp.192,453 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Immune Design Corp.Plan not statedMar 23, 2015 2015
Sold 44,464 shares at $27.52 ($1.2M)
ProQuest Investments IV, L.P., 10% owner
Sold 1.8% of holdings ($68.1M position)2.4M shares leftFiling
- 2 Form 4 sale Immune Design Corp.Plan not statedMar 25, 2015 +2 days
Sold 18,156 shares at $27.64 ($502k)
ProQuest Investments IV, L.P., 10% owner
Sold 0.7% of holdings ($67.2M position)2.4M shares leftFiling
- 3 Form 4 sale Immune Design Corp.Plan not statedApr 7, 2015 +13 days
Sold 7,495 shares at $26.72 ($200k)
ProQuest Investments IV, L.P., 10% owner
Sold 0.3% of holdings ($62.8M position)2.3M shares left0.2x usual sizeFiling
- 4 Form 4 sale Immune Design Corp.Plan not statedApr 24, 2015 +17 days
Sold 82,892 shares at $26.81 ($2.2M)
ProQuest Investments IV, L.P., 10% owner
Sold 3.7% of holdings ($60.2M position)2.2M shares left2.9x usual sizeFiling
- 5 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualAug 24, 2016 +488 days
Sold 28,870 shares at $63.00 ($1.8M)
ProQuest Investments IV, L.P., 10% owner
Sold 48.5% of holdings ($3.8M position)30,693 shares leftFirst sale on recordFiling
- 6 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualSep 21, 2016 +28 days
Sold 99,795 shares at $66.17 ($6.6M)
ProQuest Investments IV, L.P., 10% owner
Sold 77.1% of holdings ($8.6M position)29,574 shares leftFiling
- 7 Form 4 sale EAGLE PHARMACEUTICALS, INC.Plan not statedSep 30, 2016 +9 days
Sold 22,100 shares at $70.06 ($1.5M)
ProQuest Investments IV, L.P., 10% owner
Sold 0.5% of holdings ($308M position)4.4M shares leftFiling
- 8 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualNov 9, 2016 +40 days
Sold 153,830 shares at $79.29 ($12.2M)
ProQuest Investments IV, L.P., 10% owner
Sold 3.7% of holdings ($328M position)4M shares left5.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2016 | Nov 9, 2016 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 153,830 | $12.2M | 3.7% | Unusual | SEC |
| Sep 30, 2016 | Oct 4, 2016 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 22,100 | $1.5M | 0.5% | Plan not stated | SEC |
| Sep 21, 2016 | Sep 23, 2016 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 99,795 | $6.6M | 77.1% | Unusual | SEC |
| Aug 24, 2016 | Aug 25, 2016 | EAGLE PHARMACEUTICALS, INC. | 10% owner | Form 4 sale | 28,870 | $1.8M | 48.5% | Unusual | SEC |
| Apr 24, 2015 | Apr 24, 2015 | Immune Design Corp. | 10% owner | Form 4 sale | 82,892 | $2.2M | 3.7% | Plan not stated | SEC |
| Apr 7, 2015 | Apr 8, 2015 | Immune Design Corp. | 10% owner | Form 4 sale | 7,495 | $200k | 0.3% | Plan not stated | SEC |
| Mar 25, 2015 | Mar 26, 2015 | Immune Design Corp. | 10% owner | Form 4 sale | 18,156 | $502k | 0.7% | Plan not stated | SEC |
| Mar 23, 2015 | Mar 23, 2015 | Immune Design Corp. | 10% owner | Form 4 sale | 44,464 | $1.2M | 1.8% | Plan not stated | SEC |
| Mar 9, 2015 | Mar 9, 2015 | Immune Design Corp. | 10% owner | Form 4 sale | 39,446 | $1M | 1.5% | Plan not stated | SEC |